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Abstract
Sleep is an important modulator of neuroendocrine function and glucose metabolism in children as
well as in adults. In recent years, sleep curtailment has become a hallmarkof modern society with both
children and adults having shorter bedtimes than a few decades ago. This trend for shorter sleep
duration has developed over the same time period as the dramatic increase in the prevalence of obesity.
There is rapidly accumulating evidence from both laboratory and epidemiological studies to indicate
that chronic partial sleep loss may increase the risk of obesity and weight gain. The present article
reviews laboratoryevidence indicating that sleep curtailment in young adults results in a constellation
of metabolic and endocrine alterations, including decreased glucose tolerance, decreased insulin
sensitivity, elevated sympathovagal balance, increased evening concentrations of cortisol, increased
levels of ghrelin, decreased levels of leptin, and increased hunger and appetite. We also review cross-
sectional epidemiological studies associating short sleep with increased body mass index and
prospective epidemiological studies that have shown an increased risk of weight gain and obesity in
children and young adults who are short sleepers. Altogether, the evidence points to a possible role of
decreased sleep duration in the current epidemic of obesity.
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The epidemic of obesity and sleep
curtailment in adults and in children
The prevalence of obesity is increasing worldwide,
particularly in the US (1). In 2004, more than one-
third of American adults were overweight or obese (2).
Rates of overweight and obesity have also increased in
all industrialized countries, although prevalence is still
lower than that in the US. Figure 1 shows the
prevalence of obesity (body mass index (BMI)
O30 kg/m
2) in selected European countries in 1998
and 2001 (3). Prevalence rates range from less than 8%
to nearly 14%, depending on country and sex, and
remarkably the proportion of obese individuals in the
general adult population increased over the 3-year
follow-up period in all but one country. The epidemic of
obesity has not spared children. Figure 2 shows the
increase in prevalence of overweight among the US
children of ages 2–5, 6–11, and 12–19 years from the
early seventies to 2003–2004 (4). In each age group,
the prevalence of overweight approximately tripled over
these three decades.
The causes of this epidemic are not fully explained by
the changes in traditional lifestyle factors such as diet
(increases in food intake, food portions, and snacking)
and decreases in physical activity. It has been recently
proposed that shorter habitual sleep times may also be
on the causal pathways (5, 6). Indeed, one behavior
that seems to have developed over the past few decades
and has become highly prevalent, particularly among
Americans, is sleep curtailment. In 1960, a survey
study conducted by the American Cancer Society found
modal sleep duration to be 8.0 to 8.9 h (7), while in
1995 the modal categoryof the surveyconducted by the
National Sleep Foundation poll had dropped to 7 h (8).
Today, more than 30% of adult men and women
between the ages of 30 and 64 years report sleeping less
than 6 h per night (9).
Very few studies have assessed usual sleep duration
usingobjective measures, rather than self-report. One of
the ﬁrst attempts was a population-based study of 273
volunteers aged 40–60 years in San Diego, California.
This study measured sleep by wrist actigraphy in 1990–
1994 and found mean sleep duration to be 6.2 h (10).
The Sleep Heart Health Study used a single night of
in-home polysomnography among 2685 participants
with a mean age of 62 years, and the average sleep time
was 6.1 h for women and 5.7 h for men (11). More
recently, an ancillary study to the Coronary Artery Risk
Development in Young Adults (CARDIA) study, a
prospective multi-center cohort study of the evolution
of cardiovascular risk factors begun in 1985, measured
sleep in participants aged 38–50 years using wrist
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(12). In the CARDIA sleep study, mean (GS.D.) for sleep
duration was 6.1 (1.2) h, and varied between the race–
sex groups from 6.7 (0.9) h in white women to 5.1 (1.3)
h in African-American men (12). Insufﬁcient sleep
appears also highly prevalent in the US children. Thus,
all three studies that assessed sleep duration objectively
in the US adults found very similar means of sleep
duration.
Laboratory studies have shown that ‘sleep need,’
deﬁned as the amount of sleep achieved when given
10 h of nocturnal bedtime, does not change substan-
tially across adolescence (10–17 years) and is about 9 h
(13). Contrasting with this physiological sleep need of
9 h are self-reported sleep durations collected in a
sample representative of the US in a 2006 survey
conducted by the US National Sleep Foundation (14).A s
shown in Fig. 3, mean sleep duration was under 9 h in
all age groups and decreased steadily from 8.4 h at ages
11–12 years to only 6.9 h at ages 17–18 years.
Furthermore the study showed that the decrease in
sleep duration was mostly due to later bedtimes, rather
than earlier wake up times, and that the respondents
were aware of having insufﬁcient sleep.
The decrease in average sleep duration in the US has
occurred over the past three to four decades, simul-
taneous with the increase in the prevalence of obesity.
In recent years, data from both laboratory and
epidemiological studies have accumulated to support
the hypothesis that sleep curtailment may have
contributed to the increased prevalence of overweight
and obesity. Sleep curtailment may affect energy
balance and result in weight gain via three distinct
pathways: upregulation of appetite, more time to eat,
and/or a decrease in energy expenditure. Signiﬁcant
weight gain may in turn result in insulin resistance, a
condition that may promote further adiposity. Addition-
ally, up to 20% of overweight and obese individuals
suffer from sleep-disordered breathing (SDB), an inde-
pendent risk factor for insulin resistance (15, 16).
Indeed, there is a substantial body of evidence to
indicate that sleep fragmentation, hypoxia, and low
levels of deep non-rapid eye movement (REM) sleep as
occur in SDB may all contribute to reduce insulin
sensitivity (16–18). The present article will, however,
focus on sleep loss resulting only from behavioral
sleep restriction rather than that from the presence of
a sleep disorder.
Laboratory studies linking sleep loss and
upregulation of appetite
Early studies reported increased food intake in human
subjects and in laboratory rodents submitted to total
sleep deprivation (19, 20). More recent studies that
have examined appetite regulation under the much
more common condition of partial chronic sleep
deprivation are summarized below.
Figure 1 Prevalence of obesity (BMIO30 kg/m
2) in nine European
countries in 1998 and 2001 (adapted from Ref. (3)).
Figure 2 Prevalence of overweight (deﬁned as above the 95th
percentile for age and sex) among the US children of ages 2–5,
6–11, and 12–19 years in 1971–1972, 1976–1980, 1988–1994,
1999–2000, 2001–2002, and 2003–2004 (adapted from Ref. (4)).
Figure 3 Self-reported sleep duration (hours) by age for the US
children aged 11–18 years (14).
S60 E Van Cauter and K L Knutson EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008) 159
www.eje-online.orgThe ‘Sleep Debt Study’: 6 days with 4-h
bedtimes
The ﬁrst detailed laboratory study that examined the
effects of recurrent partial sleep deprivation on hormo-
nal and metabolic variables involved in appetite
regulation included healthy young men who were
subjected to six nights of 4 h in bed (‘sleep debt’)
followed by seven nights of 12 h in bed (‘sleep recovery’)
(21). The subjects also underwent a baseline study with
the recommended 8-h bedtimes. They ate identical
carbohydrate-rich meals and were at continuous bed
rest on the last 2 days of each bedtime condition. At the
end of each condition, the subjects underwent an i.v.
glucose tolerance test (ivGTT) followed by a 24-h period
of blood sampling at 10–30 min intervals to assess
glucose and hormonal proﬁles.
The upper panels of Fig. 4 shows the mean proﬁles of
plasma leptin observed under the three conditions (22).
Leptin is a peripheral endocrine signal released by the
adipocytes, which conveys information regarding
energy balance to the brain. Leptin is a satiety factor:
high leptin levels inhibit and low leptin levels stimulate
hunger and food intake respectively. The data shown in
Fig. 4 demonstrate that leptin levels are remarkably
sensitive to sleep duration, with a ‘dose–response’
relationship between sleep duration and leptin consist-
ent with increased hunger when sleep is curtailed.
Indeed, on average, mean leptin levels were 19% lower
when the subjects had 4 h in bed than when they were
presumably fully rested, after 6 days with 12 h in bed.
The normal nocturnal acrophase of peripheral leptin
concentrations was 2 h earlier and 26% lower and the
amplitude of the diurnal variation was 20% lower
during sleep restriction when compared with the fully
rested condition (22). Remarkably, these changes
occurred despite identical caloric intake. Differences in
energy expenditure between the two bedtime conditions
were minimal because the subjects were at bed rest. In
ongoing studies, our group has preliminary evidence
indicating that the extension of the waking period in
humans studied under comfortable sedentary con-
ditions is not associated with an increase in energy
requirement as assessed by the doubly labeled water
method (23). The difference in maximal leptin levels
between the state of sleep debt and the fully rested state
was somewhat larger than the decrease reported in a
separate study in young adults submitted to 3 days of
dietary intake restricted to 70% of energy requirements
(a caloric deﬁcit of w900 kcal/day) (24). Thus, in the
state of sleep debt, leptin levels were inaccurately
signaling a state of substantial caloric deﬁcit. Unfortu-
nately, subjective feelings of hunger and appetite were
not assessed in this ﬁrst ‘Sleep Debt Study’.
It is well known that glucocorticoids increase food
intake and, in the same Sleep Debt Study, alterations in
the 24-h proﬁle of circulating cortisol levels were also
observed (shown in the middle panels of Fig. 4). While
24-h mean levels were similar under the three bedtime
conditions, sleep duration affected cortisol levels in the
late afternoon and evening (shaded areas) with a graded
Figure 4 Mean(GS.E.M.)24-hleptin,cortisol,and HOMAproﬁleswith4-,8-,and12-hbedtimes. Notethattherelativesynchronizationofthe
leptin and cortisol proﬁles in the study with 8-h bedtimes was intermediate between that observed with 4-h bedtimes and that observed with
12-hbedtimes.Similarly,theHOMAresponsetobreakfastgraduallyincreasedfromthe12-hbedtimeconditiontothe4-hbedtimecondition,
with an intermediate response during the 8-h bedtime condition. Black bars, Sleep periods. (Copied with permission from Ref. (22)).
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levels (22). The nadir of cortisol concentrations
occurred w1.5 h later when subjects had 4-h bedtimes
as compared with when they had 12-h bedtimes. Leptin
and cortisol levels varied in a mirror image throughout
the 24-h cycle when the subjects were fully rested, and
maximum leptin levels were essentially aligned with
minimum cortisol concentrations. This inverse relation-
ship was disrupted following sleep restriction. Leptin
levels stopped rising in the early evening, when cortisol
concentrations were still declining, and this curtailment
of the leptin elevation was quantitatively associated
with the concomitant elevation of evening cortisol
levels. The study further revealed that alterations of the
24-h leptin proﬁle resulting from sleep restriction in
healthy individuals studied under conditions of stable
caloric intake and activity levels were associated with
an increase in cardiac sympathovagal balance (22).
Another ﬁnding of this ﬁrst laboratory study of
metabolic alterations resulting from the experimental
buildup of a sleep debt was a nearly 40% decrease in
glucose tolerance to levels consistent with a state of
impaired glucose tolerance (21). Reduced glucose toler-
anceto ivGTT was associated with a marked reduction in
acute insulin response to glucose and a trend for reduced
insulin sensitivity. The combination of these two defects
resulted in a marked decrease in the so-called disposition
index(DI),avalidatedmarkerofdiabetesriskwherelowDI
values indicate an elevated risk of type 2 diabetes. The
lower panels of Fig. 4 show the proﬁles of homeostasis
modelassessment(HOMA)values(glucoseconcentration
(mmol/l)!insulinconcentration(mIU/l)dividedby22.5)
calculatedforeachtimepoint.FastinglevelsofHOMAare
a validated measure of insulin sensitivity, but HOMA
values during meal ingestion were used here as an
integratedmeasureoftheglucoseandinsulinresponsesto
the three identical carbohydrate-rich meals ingested
during the study. The post-breakfast HOMA (shown as a
shadedarea)wassigniﬁcantlyelevated(C56%)whenthe
subjects were in a state of sleep debt, as compared with
fully rested, and the response was intermediate when the
subjects had 8 h in bed. Subsequent studies of more
extended periods of less rigorous sleep restriction (e.g. 8
nights with 5 h in bed) have revealed a consistent decline
in insulin sensitivity without appropriate compensation
by b-cell responsiveness, and thus an increase in diabetes
risk. In summary, reduced insulin sensitivity is another
possible mechanism by which a state of sleep debt might
increase the risk of weight gain and obesity.
Randomized crossover design study: 2 days of
4 vs 10 h in bed
TheinitialSleepDebtStudyinvolvedapossibleordereffect
since sleep recovery during extended nights follows the
buildup of the sleep debt. A subsequent laboratory study
addressedthislimitationbyusingarandomizedcrossover
designtocomparetheimpactofrestrictedversusextended
sleepandobservedconsistenteffectsofsleeprestrictionon
appetiteregulation(25).Thisstudyinvolved2daysof4-h
bedtimesand2daysof10-hbedtimesinsubjectsreceiving
a constant glucose infusion as their only source of caloric
intake. Daytime levels of leptin, ghrelin, hunger, and
appetite were measured at frequent intervals after the
secondnightofsleeprestrictionorextension(25).Ghrelin
is a hunger hormone primarily secreted by the stomach,
which appears to act independently of leptin. Table 1
summarizes the changes in leptin, ghrelin, hunger, and
appetite when sleep was restricted as compared to
extended (25). Importantly, the change in the ratio of
ghrelin-to-leptinbetweenthetwoconditionswasstrongly
correlated to the change in hunger ratings, suggesting
that the changes observed in these appetite hormones
were partially responsible for the increase in appetite and
hunger.Theseobservedchangeswouldsuggestthatthese
subjects,ifallowedunlimitedamountsoffood,wouldhave
increased their food intake. After sleep restriction, the
increase in appetite was particularly strong for nutrients
withahighcarbohydratecontent(Table 1)asifthesleep-
deprived brain craved its primary fuel, glucose.
Population-based studies
Two population-based studies in adults, The Wisconsin
SleepCohortStudy(26)andthe‘QuebecenForme’study
from Canada (27) also observed an association between
short sleep duration and changes in leptin and/or
ghrelin consistent with an upregulation of appetite.
Both studies included a large number of subjects,
measured hormonal levels on a single sample, and
controlled for the degree of adiposity. Remarkably, as
illustrated in Fig. 5, the ﬁndings from these two
Table 1 Summary of effects of 4- and 10-h bedtimes hunger and appetite were measured on visual analogue scales.
Mean (GS.E.M.) levels
After 2 days of 4-h
bedtime
After 2 days of 10-h
bedtime Change (%) P
Plasma leptin (ng/ml) 2.1G0.4 2.6G0.5 K18 0.04
Plasma ghrelin (ng/ml) 3.3G0.2 2.6G0.2 C28 !0.04
Ghrelin/leptin ratio 2.3G0.4 1.6G0.3 C71 !0.07
Hunger (0–10 cm) 7.2G0.4 6.0G0.5 C24 !0.01
Global appetite (0–70 cm) 47.7G3.4 39.7G3.0 C23 0.01
Appetite for high carbohydrate food (0–30 cm) 20.6G1.4 16.3G1.3 C32 !0.02
Appetite for other food types (0–40 cm) 27.1G2.2 23.4G1.8 C18 !0.2
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in agreement with the ﬁndings of the laboratory study.
A recent report examining sleep duration, resting
energy expenditure, and leptin levels in children and
adolescents aged 6–20 years found that resting energy
expenditure was lower among short sleepers in boys
after an adjustment for age and fat free mass, and that
leptin levels were higher among short sleepers in girls
after an adjustment for waist circumference (28). These
results suggest a possible gender difference in the impact
of sleep duration on leptin levels and energy expendi-
ture, at least during childhood and adolescence.
Epidemiological studies linking short
sleep and increased risk of obesity
A rapidly growing body of epidemiological evidence
supports the ﬁndings from the laboratory studies.
Table 2 summarizes the studies published as of April
10, 2008. Taken together, the studies have involved
thousands of subjects, both adults and children of all
ages. They have originated from multiple industrialized
countries and have involved diverse populations in
terms of sex, age, and BMI distribution. Patel & Hu (29)
have recently provided a careful review of the evidence
and pointed out that the impact of short sleep on obesity
risk appears greater in children than adults, and greater
in young adulthood than in midlife or late life. This
systematic review identiﬁed six cross-sectional studies
with negative ﬁndings or with positive ﬁndings in only
one sex group (out of a total of 20 cross-sectional studies
in adults included in this analysis). One of the studies
characterized as negative (12) focused on race–sex
differences in sleep duration and quality objectively
assessed by wrist actigraphy in the CARDIA Chicago
cohort. Indeed, in this analysis, BMI was not a
signiﬁcant mediator of race–sex differences in sleep.
For the purpose of the present article, we identiﬁed ﬁve
more cross-sectional studies in adults not included in
the Patel & Hu review (30–34) and therefore, to date,
there have only been four studies (32, 35–37) out of a
total of 25 that have not observed a cross-sectional
association between short sleep and the risk of over-
weight/obesity in adults of either sex. Of note, two of
these studies included only participants over 50 years of
age (32, 35). Cross-sectional studies cannot address the
causal direction between sleep duration and weight;
however, there have also been prospective studies that
have observed an association between sleep duration
and weight gain, including four studies in children
(38–41) and ﬁve in adults (30, 42–45). All but one (30)
of these prospective studies found a signiﬁcant associ-
ation between shorter sleep duration at baseline and
greater weight gain during the period of follow-up.
Figure 5 Percent difference in levels of leptin and ghrelin comparing short sleep to longer sleep conditions from three different
studies (25–27).
Table 2 Number of publishedepidemiological studies on the relationship between sleep duration and body mass index (BMI) or prevalence
or incidence of overweight/obesity.
Number of studies in children Number of studies in adults Total number of studies
Positive ﬁndings
Total number of
studies Positive ﬁndings
Total number of
studies Positive ﬁndings
Total number of
studies
Cross-sectional
studies
13 13 21 25 34 38
Prospective
studies
444589
All studies 7 7 25 30 42 47
References for each study can be found in the 2008 review by Patel & Hu (30) with the following additions that were not included in the Patel & Hu review.
Cross-sectional studies in children: Nixon, Sleep 2008 (55) and Yu, Sleep 2007 (56). Cross-sectional studies in adults: Stranges, AJE 2008 (30); Lopez-Garcia
AJCN 2008 (31), Littman et al. 2006 (negative) (32), Rontoyanni 2007 (33), Bjorvatn 2007 (34). Prospective studies in children: Lumeng et al. (40), Taveras
et al. 2008 (41), prospective studies in adults: Chaput et al. 2008 (45), Stranges, AJE 2008 (30).
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and risk of weight gain and obesity
In summary, the ﬁndings from laboratory studies
indicate that reduced sleep duration may increase the
risk of weight gain and obesity by upregulating appetite
via a decrease in leptin, an increase in ghrelin, and a
reduction in insulin sensitivity. Limited evidence from
population studies support a role for leptin in the link
between short sleep and higher BMI.
It is likely that the orexin system is pivotal in these
interactions between sleeping and feeding. Orexins (also
called hypocretins) are two distinct peptides (orexin A
and B) that were discovered in 1998 and are
synthesized mainly by neurons in the lateral hypo-
thalamus. These neurons play a central role in the
maintenance of arousal. Orexins (as suggested by their
name) also increase feeding (46, 47), particularly at a
time when normal food intake is low. Feeding requires
the maintenance of wakefulness and the orexin system
appears to be the crucial link in this vital interaction
between feeding and arousal. Orexin neurons are active
during the waking phase, in synchrony with neuronal
activity in other arousal centers, and inactive during
slow-wave sleep. Orexins activate all the components of
the ascending arousal system, and orexin neurons also
project diffusely to the entire cerebral cortex (48).
Consistent with the fact that sympathetic nervous
activity is higher during waking than during sleeping,
orexin activity is associated with increased sympathetic
tone, and excitatory effects of the orexin peptides have
been observed for neurons of the nucleus tractus
solitarius and for neurons of the hypothalamic para-
ventricular nucleus (49).I na n i m a lm o d e l s ,s l e e p
deprivation upregulates central orexin activity (50–
52). Higher orexinergic activity promotes sympathetic
nervous tone and activity of the appetite-stimulating
neuropeptide Y (NPY) neurons of the arcuate nucleus.
Increased sympathetic nervous activity associated
with sleep deprivation is a likely mediator of several
of the peripheral effects of sleep loss, including the
reduction in leptin release from the adipocytes, the
reductionintotalbodyinsulin sensitivity,andthefailure
of b-cells to adequately compensate for the decrease in
insulin sensitivity.
The notion of ‘leptin resistance’ has been introduced to
explain the paradoxical observation that most obese
individuals have high, rather, than low plasma leptin
levels, despite their ample energy stores. While a number
of putative mechanisms have been proposed to underlie
leptin resistance, one suggestion that may be particularly
relevant to the studies of sleep loss is the hypothesis that
leptin binds to circulating levels of C-reactive protein
(CRP),aninﬂammatorymarker thatiselevatedinobesity
(53). Higher CRP levels would result in a decrease in
unbound,freeleptinwithareductioninitscentralactions.
Several studies of acute total sleep deprivation as well as
recurrent partial sleep deprivation in healthy lean adults
havereportedanelevationofCRPwithsleeploss(54) and
ongoing studies from our laboratory conﬁrm these
ﬁndings. The combination of reduced leptin levels with
increased CRP concentrations in sleep-deprived subjects
may amplify the effects of the leptin reduction alone.
Conclusions
Findings from laboratory studies in young adults and
epidemiological studies in both children and adults
converge to suggest that partial chronic sleep restric-
tion, an increasingly prevalent behavior in modern
society, may increase the risk of weight gain and play a
role in the current epidemic of obesity.
One of the many present challenges for this emerging
ﬁeld of enquiry will be to translate the ﬁndings from
short-term well-controlled laboratory studies in small
numbers of subjects to the lifetime trajectory of weight
gain observed in large populations. Thus, laboratory
studies will need to be complemented by the studies
conducted in real-life conditions over longer periods of
follow-up with an accurate monitoringof sleep duration
and quality and energy balance. Another important
issue is the temporal window of metabolic vulnerability
to sleep loss. Indeed, whether sleep restriction may have
a different impact in normal weight individuals with
high insulin sensitivity, i.e. prior to the development of
obesity, versus obese individuals with low insulin
sensitivity, i.e. when obesity is already established, is
not known. When comparing epidemiological studies
originating from different countries (e.g. Europe versus
US), it should be noted that the negative relationship
between sleep duration and BMI has been found for
populations with variable degrees of obesity. The
observation that the impact of sleep duration and
quality on the risk of obesity may be greater in children
than adults suggests that efforts to educate the public
regarding the potential deleterious effects of sleep
curtailment on long-term health and well-being should
start in early life and involve parents, educators, and
health care providers.
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